The use of biologic mediators and tissue engineering in dentistry
2009; Wiley; Volume: 50; Issue: 1 Linguagem: Inglês
10.1111/j.1600-0757.2008.00287.x
ISSN1600-0757
AutoresRichard T. Kao, Shinya Murakami, O. Ross Beirne,
Tópico(s)dental development and anomalies
ResumoPeriodontology 2000Volume 50, Issue 1 p. 127-153 The use of biologic mediators and tissue engineering in dentistry Richard T. Kao, Richard T. KaoSearch for more papers by this authorShinya Murakami, Shinya MurakamiSearch for more papers by this authorO. Ross Beirne, O. Ross BeirneSearch for more papers by this author Richard T. Kao, Richard T. KaoSearch for more papers by this authorShinya Murakami, Shinya MurakamiSearch for more papers by this authorO. Ross Beirne, O. Ross BeirneSearch for more papers by this author First published: 08 April 2009 https://doi.org/10.1111/j.1600-0757.2008.00287.xCitations: 60Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Physician labeling (3/8/2007). Infuse ® bone graft for certain oral maxillofacial and dental regenerative uses, Important medical information, Rx only. Retrieved 12/18/2007 from the US Federal and Drug Administration site, http://www.fda.gov/cdrh/pdf5/p050053c.pdr. 2 Aghaloo TL, Moy PK. Which hard tissue augmentation techniques are the most successful in furnishing bony support for implant placement? Int J Oral Maxillofac Implants 2007: 22(suppl): 49–70. Erratum in 2008: 23: 56. 3 Aimetti M, Romano F, Pigella E, Piemontese M. Clinical evaluation of the effectiveness of enamel matrix proteins and autologous bone graft in the treatment of mandibular class II furcation defects: a series of 11 patients. Int J Periodontics Restorative Dent 2007: 27: 441–447. 4 Alhadlaq A, Mao JJ. Tissue-engineered neogenesis of human-shaped mandibular condyle from rat mesenchymal stem cells. J Dent Res 2003: 82: 951–956. 5 Alhadaq A, Mao JJ. Tissue engineered osteochondral constructs in the shape of an articular condyle. J Bone Joint Surg Am 2005: 87: 936–944. 6 Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999: 14: 529–535. 7 Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004: 91: 4–15. 8 Anusaksaathien O, Jin Q, Zhao M, Somerman MJ, Giannobile WV. Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue engineered cementum. J Periodontol 2004: 75: 429–440. 9 Barber TA, Golledge SL, Castner DG, Healy KE. Peptide-modified p(AAm-co-EG/AAc) IPNs grafted to titanium modulate osteoblast behavior in vitro. J Biomed Mater Res 2003: 64: 38–47. 10 Barboza EP, Duarate ME, Geolas L, Sorensen RG, Riedel GE, Wikesjo UM. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog. J Periodontol 2000: 71: 488–496. 11 Bateman J, Intini G, Margarone J III, Goodloe S, Bush P, Lynch SE, Dziak R. Platelet-derived growth factor enhancement of two alloplastic matrices. J Periodontol 2005: 76: 1833–1844. 12 Beardmore AA, Brooks DE, Wenke JC, Thomas DB. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone graft substitute. J Bone Joint Surg Am 2005: 87: 107–112. 13 Becker W, Urist MR, Tucker LM, Becker BE, Ochsenbein C. Human demineralized freeze-fried bone: inadequate induced bone formation in athymic mice, a preliminary report. J Periodontol 1995: 66: 822–828. 14 Becker W, Urist MR, Becker BE, Jackson W, Parry DA, Bartold M, Vincenzzi G, De Georges D, Niederwanger M. Clinical and histologic observation of sites implanted with intraoral autologous bone grafts or allografts. 15 human case reports. J Periodontol 1996: 67: 1025–1033. 15 Bowen JA, Mellonig JT, Gray JL, Towle HT. Comparison of decalcified freeze-dried bone allograft and porous particulate hydroxyapatite in human periodontal defects. J Periodontol 1989: 60: 647–654. 16 Boyne PJ. Animal studies of the application rhBMP-2 in maxillofacial reconstruction. Bone 1996: 19(Suppl. 1): 83S–92S. 17 Boyne PJ, Lilly LC, Marx RE, Moy PK, Nevins M, Spagnoli DB, Triplett G. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005: 63: 1693–1707. 18 Boyne PJ, Marx RE, Nevins M, Triplett G, Lazaro E, Lilly LC, Alder M, Nummikoski P. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1977: 17: 11–25. 19 Camelo M, Nevins ML, Schenk RK, Lynch SE, Nevins M. Periodontal regeneration in human class II furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft. Int J Periodontics Restorative Dent 2003: 23: 213–225. 20 Cancedda R, Giannoni P, Mastrogiacomo M. A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007: 28: 4240–4250. 21 Carter TG, Brar PS, Tolas A, Beirne OR. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2). Bio-implants for the reconstruction of mandibular defects in humans: report of five cases. J Oral Maxillofac Surg (accepted for publication). 22 Chong CH, Carnes DL, Moritz AJ, Oates T, Ry OH, Simmer J, Cochran DL. Human periodontal fibroblasts response to enamel matrix derivative, amelogenin, and platelet-derived growth factor-BB. J Periodontol 2006: 77: 1242–1252. 23 Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999: 70: 139–150. 24 Cochran DL, Jones AA, Lilly LC, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000: 71: 1241–1257. 25 Danos N, Glavind L, Karring T, Sculean A. Clinical evaluation of an enamel matrix derivative in the treatment of mandibular degree II furcation involvement: a 36-month case series. Int J Periodontics Restorative Dent 2003: 23: 507–512. 26 Doadrio JC, Acros D, Cabanas MV, Vallet-Regi M. Calcium sulfate-based cements containing cephalexin. Biomaterials 2004: 25: 2629–2635. 27 Dori F, Huszar T, Nikolidakis D, Arweiler N, Gera I, Sculean A. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral and expanded polytetrafluoroethylene membranes. J Periodontol 2007: 78: 983–990. 28 El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke T. Platelet-rich plasma: Growth factors and pro- and anti-inflammatory properties. J Periodontol 2007: 78: 661–669. 29 Fagan MC, Miller RE, Lynch SE, Kao RT. Simultaneous augmentation of hard and soft tissues for implant site preparation using recombinant human platelet-derived growth factor: a human case report. Int J Periodontics Restorative Dent 2008: 28: 37–41. 30 Fang J, Zhu YY, Smiley E, Bonadio J, Rouleau JP, Goldstein SA, McCauley LK, Davidson BL, Roessler BJ. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA 1996: 93: 5753–5758. 31 Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005: 76: 605–613. 32 Franceschi RT, Yang S, Rutherford RB, Krebsbach PH, Zhao M, Wang D. Gene therapy approaches for bone regeneration. Cells Tissues Organs 2004: 176: 95–108. 33 Friedenstein A, Kuralesova AI. Osteogenic precursor cells of bone marrow in radiation chimeras. Transplantation 1974: 12: 99–108. 34 Froum S, Stahl SS. Human intraosseous healing responses to the placement of tricalcium phosphate ceramic implants II. 13 to 18 months. J Periodontol 1987: 58: 103–109. 35 Froum SJ, Weinberg MA, Rosenberg E, Tarnow D. A comparative utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 2001: 72: 25–34. 36 Galli C, Macaluso GM, Guizzaardi S, Vescovini R, Passeri M, Passeri G. Osteoprotegrin and receptor activator of nuclear factor-kappa B ligand modulation by enamel matrix derivative in human alveolar osteoblasts. J Periodontol 2006: 77: 1223–1228. 37 Garrett S. Periodontal regeneration around natural teeth. Ann Periodontol 1996: 1: 621–666. 38 Gerhart TN, Kirker-Head CA, Kriz MJ, Holtrop ME, Hennig GE, Hipp J, Schelling SH, Wange E. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop Rel Res 1993: 293: 317–326. 39 Gestrelius S, Andersson C, Lidstrom D, Hammerstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1977: 24: 685–692. 40 Giannobile WV, Finkelman RD, Lynch SE. Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J Periodontol 1994: 65: 1158–1168. 41 Giannobile WV, Lee CS, Tomala MP, Tejeda KM, Zhu Z. Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol 2001: 72: 815–823. 42 Giannobile WV, Ryan S, Shih MS, Su DL, Kaplan PL, Chan TC. Recombinant human osteogenic protein-1 (OP-1) promotes periodontal wound healing in class III furcation defects. J Periodontol 1998: 69: 129–137. 43 Giannobile WV, Hernandez RA, Finkelman RD, Ryan S, Kiritsh CP, D'Andrea M, Lynch SE. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res 1996: 31: 301–312. 44 Gibran NS, Isik FF, Heimbach DM, Gordon D. Basic fibroblast growth factor in the early human burn wound. J Surg Res 1994: 56: 226–234. 45 Gospondarowicz D, Massoglia S, Cheng J, Fujii DK. Effect of retina-derived basic and acidic fibroblast growth factor and lipoproteins on the proliferation of retina-derived capillary endothelial cells. Exp Eye Res 1986: 43: 459–476. 46 Gronowicz G, McCarthy MB. Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 1996: 14: 878–887. 47 Guida L, Annunziata M, Belardo S, Farina R, Scabbia A, Trombelli L. Effect of autogenous cortical bone particulate in conjunction with enamel matrix derivative in the treatment of periodontal intraosseous defects. J Periodontol 2007: 78: 231–238. 48 Habers GM, Healy KE. The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J Biomed Mater Res 2005: 15: 855–869. 49 Hagewald S, Pischon N, Jawor P, Bernimoulin JP, Zimmermann B. Effects of enamel matrix derivative on proliferation and differentiation of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004: 98: 243–249. 50 Hakki SS, Wang D, Franceschi R, Somerman M. Bone sialoprotein gene transfer to periodontal ligament cells may not be sufficient to promote mineralization in vitro or in vivo. J Periodontol 2006: 77: 1167–1173. 51 Hammarstrom L, Heijl L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix derivative. J Clin Periodontol 1997: 24: 669–684. 52 Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjo UM. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillafac Implants 1997: 12: 604–610. 53 He J, Jiang J, Safavi KE, Spanberg LS, Zhu Q. Direct contact between enamel matrix derivative (EMD) and osteoblasts is not required for EMD-induced cell proliferation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004: 98: 370–375. 54 He J, Jiang J, Safavi KE, Spangberg LS, Zhu Q. Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004: 97: 239–245. 55 Healy KE, Rezania A, Stile RA. Designing biomaterials to direct biological responses. Ann NY Acad Sci 1999: 18: 24–35. 56 Heard RH, Mellonig JT, Brunsvold MA, Lasho DJ, Meffert RM, Cochran DL. Clinical evaluation of wound healing following multiple exposures to enamel matrix protein derivative in the treatment of intrabony periodontal defects. J Periodontol 2000: 71: 1715–1721. 57 Heden G, Wennstrom JL. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. J Periodontol 2006: 77: 295–301. 58 Heden G. A case report study of 72 consecutive Emdogain-treated intrabony periodontal defects: clinical and radiographic findings after 1 year. Int J Periodontics Restorative Dent 2000: 20: 127–139. 59 Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997: 24: 693–696. 60 Heijl L, Heden G, Svardstrom G, Ostgren A. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997: 24: 705–714. 61 Heng N, N'Guessan P, Kleber N, Bernimoulin J, Pischon N. Enamel matrix derivative induces connective tissue growth factor expression in human osteoblastic cells. J Periodontol 2007: 78: 2369–2379. 62 Hereford AS, Boyne PJ. Reconstruction of continuity defects with bone morphogenic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008: 66: 616–624. 63 Herford AS, Boyne PJ, Williams RP. Clinical applications of rhBMP-2 in maxillofacial surgery. J Calif Dent Assoc 2007: 35: 335–341. 64 Hollister SJ, Lin CY, Saito E, Lin CY, Schek RD, Taboas JM, Williams JM, Partee B, Flanagan DL, Diggs A, Wilke EN, Van Lenthe GH, Muller R, Wirtz T, Das S, Feinberg SE, Drebsbach PH. Engineering craniofacial scaffolds. Orthod Craniofac Res 2005: 8: 162–173. 65 Hou LT, Tsai AY, Liu CM, Feng F. Autologous transplantation of gingival fibroblast-like cells and a hydroxylapatite complex graft in the treatment of periodontal osseous defects: cell cultivation and long-term report of cases. Cell Tranplant 2003: 12: 787–797. 66 Hou L, Liu C, Liu B, Change P, Chen M, Ho M, Jehng S, Liu H. Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2 – atelocollagen composite scaffolds. J Periodontol 2007: 78: 335–343. 67 Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, Giannobile WV, Lynch SE. A phase I/II trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997: 68: 1186–1193. 68 Howell TH, Fiorellini J, Jones A, Alder M, Nummikoski P, Lazaro M, Lilly L, Cochran D. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997: 17: 124–139. 69 Ishikawa I, Kinashita A, Oda S. Regenerative therapy in periodontal disease. Histological observation after implantation of rhBMP-2 in surgically created periodontal defects in dogs. Dent Jpn 1994: 31: 141–148. 70 Izumi K, Feinberg SE, Iida A, Yoshizawa M. Intraoral grafting of an ex vivo produced oral mucosa equivalent: a preliminary report. Int J Oral Maxillofac Surg 2003: 32: 188–197. 71 Jergessen HE, Chua J, Kao R, Kaban LB. Age effects on bone induction by demineralized bone powder. Clin Orthopaedic and Rel Res 1991: 268: 253–259. 72 Jiang J, Fouad AF, Safavi KE, Spangberg LS, Zhu Q. Effects of enamel matrix derivative on gene expression of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001: 91: 95–100. 73 Jin QM, Anusaksathien O, Webb SA, Rutherford RB, Giannobile WV. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 2003: 74: 202–213. 74 Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004: 9: 519–526. 75 Jin QM, Zhao M, Economides AN, Somerman M, Giannobile WV. Noggin gene delivery inhibits cementoblast-induced mineralization. Connect Tissue Res 2004: 45: 50–59. 76 Jotereau FV, Le Douarin NM. The developmental relationship between osteocytes and osteoclasts: a study using the quail-chick nuclear marker in endochondral ossification. Develop Biol 1978: 63: 253–265. 77 Juncosa-Melvin N, Boivin GP, Galloway MT, Gooch C, West JR, Skenka AM, Butler DL. Effects of cell-to-collagen ratio in mesenchymal stem cell-seeded implants on tendon repair. Tissue Eng 2005: 11: 448–457. 78 Kaigler D, Mooney D. Tissue engineering's impact on dentistry. J Dent Educ 2001: 65: 456–462. 79 Kao RT. Periodontal regeneration and reconstructive surgery. In: LF Rose, BL Mealey, RJ Genco, DW Cohen, editors. Periodontics. St Louis: Elsevier Mosby, 2004: 572–609. 80 Kao ST, Scott DD. A review of bone substitutes. Oral Maxillofac Surg Clin North Am 2007: 19: 513–521. 81 Kim CK, Kim HY, Chai JK. Effect of calcium sulfate implant with calcium sulfate barrier on periodontal healing in 3-wall intrabony defects in dogs. J Periodontol 1998: 69: 982–988. 82 King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J Periodontol 2002: 73: 925–936. 83 King GN, King N, Cruchley AT, Wozney JM, Hughes FJ. Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J Dent Res 1997: 76: 1460–1470. 84 Kitamura M, Nakashima K, Kowashi Y, Fujii T, Shimauchi H, Sasano T, Furuichi T, Fukuda M, Noguchi T, Shibutani T, Iwayama Y, Takashiba S, Kurihara H, Ninomiya M, Kido J, Nagata T, Hamachi T, Maeda K, Hara Y, Izumi Y, Hirofuji T, Imai E, Omae M, Watanuki M, Murakami S. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS ONE 2008: 3(7): e2611. 85 Krebsbach PH, Robey PG. Dental and skeletal stem cells; potential cellular therapeutics for craniofacial regeneration. J Dent Educ 2002: 66: 766–772. 86 Lam KH, Schakenraad JM, Esselbrugge H, Feijen J, Nieuwenhuis P. The effect of phagocytosis of poly (L-lactic acid) fragments on cellular morphology and viability. J Biomed Mater Res 1993: 27: 1569–1577. 87 Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 2000: 58: 297–300. 88 Ledoux D, Gannoun-Zaki L, Barritault D. Interactions of FGFs with target cells. Prog Growth Factor Res 1992: 4: 107–120. 89 Lekovic V, Camargo PM, Weinlaender PM, Nedic M, Aleksic Z, Kenny EB. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony defects in human. J Periodontol 2000: 71: 1110–1116. 90 Lind M. Growth factors: possible new clinical tools. A review. Acta Orthop Scand 1996: 67: 407–421. 91 Lynch SE, Williams RC, Polson AM, Howell TH, Reddy MS, Zappa UE, Antoniades HN. A combination of platelet-derived and insulin-like growth factors enhanced periodontal regeneration. J Clin Periodontol 1989: 16: 545–548. 92 Lynch SE, Ruiz de Castilla G, Williams RC, Kiritsy CP, Howell TH, Reddy MS, Antoniades HN. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991: 62: 458–467. 93 Lynch SE. Introduction to tissue engineering. In: SE Lynch, RJ Genco, RE Marx, editors. Tissue engineering: applications in maxillofacial surgery and periodontics. Hanover, IL: Quintessence Publishing Co, 1999: xi–xviii. 94 Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998: 85: 638–646. 95 Massague J. TGF-β signal transduction. Ann Rev Biochem 1998: 67: 753–791. 96 McGuire MK, Nunn ME. Evaluation of the safety and efficacy of periodontal applications of a living tissue-engineered human fibroblast-derived dermal substitute. I. Comparison to the gingival autograft: a randomized controlled pilot study. J Periodontol 2005: 76: 867–880. 97 McGuire MK, Kao RT, Nevins M, Lynch SE. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations. Int J Periodontics Restorative Dent 2006: 26: 223–231. 98 Mellonig JT. Freeze-dried bone allografts in periodontal reconstructive surgery. Dent Clin N Am 1991: 35: 505–520. 99 Mellonig JT, Captain DC. Decalcified freeze-dried bone allograft as an implant material in human periodontal defects. Int J Periodontics Restorative Dent 1984: 4: 41–56. 100 Mellonig JT, Bowers GM, Bright RW, Lawrence JJ. Clinical evaluation of freeze-dried bone allografts in periodontal osseous defects. J Periodontol 1976: 47: 125–138. 101 Miyamoto S, Takaoka K, Okada T, Yoshikawa H, Hashimoto J, Suzuki S, Ono K. Evaluation of polylactic acid homopolymers as a carrier for bone morphogenetic protein. Clin Orthop 1992: 278: 274–286. 102 Momose M, Murata M, Kato Y, Okuda K, Yamazaki K, Shinohara C, Yoshi H. Vascular endothelial growth factors and transforming growth factor-∂ and β are released from human cultured gingival epithelial sheets. J Periodontol 2002: 73: 749–775. 103 Murakami S, Takayama S, Kitamura M, Shimabukuro Y, Yanagi K, Ikezawa K, Saho T, Nozaki T, Okada H. Recombinant human basic fibroblast growth factor (bFGF) stimulates periodontal regeneration in class II furcation defects created in beagle dogs. J Periodontal Res 2003: 38: 97–103. 104 Nagano T, Oida S, Suzuki S, Iwata T, Yamakoshi Y, Ogata Y, Gomi K, Arai T, Fukae M. Porcine enamel protein fractions contain transforming growth factor-β1. J Periodontol 2006: 77: 1688–1694. 105 Nevins M, Hanratty H, Lynch SE. Clinical results using recombinant human platelet-derived growth factor and mineralized freeze-dried bone allograft in periodontal defects. Int J Periodontics Restorative Dent 2007: 27: 421–427. 106 Nevins M, Camelo M, Nevins ML, Schenk RK, Lynch SE. Periodontal regeneration in humans using recombinant human platelet-derived growth factor BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003: 74: 1282–1292. 107 Nevins M, Kirker-Head C, Nevins M, Wozney JA, Palmer R, Graham D. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. Int J Periodont Rest Dent 1996: 16: 8–19. 108 Nevins M, Giannobile WV, McGuire MK, Kao RT, Mellonig JT, Hinrichs J, McAllister BS, Murphy KS, McClain PK, Nevins M, Paquette DW, Han TJ, Reddy MS, Lavin PT, Genco RJ, Lynch SE. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 2005: 76: 2205–2215. 109 Okuda K, Momose M, Miyazaki A, Murata M, Yokoyama Y, Wolff LF, Yoshie H. Enamel matrix derivative in the treatment of human intrabony osseous defects. J Periodontol 2000: 71: 1821. 110 Okuda K, Momose M, Murata M, Saito Y, Inoie M, Shinohara C, Wolff LF, Yoshi H. Treatment of chronic desquamative gingivitis using tissue-engineered human cultured gingival epithelial sheets: a case report. Int J Periodontics Restorative Dent 2004: 24: 119–125. 111 Okumura M, Okuda T, Nakamura T, Yajima M. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 1996: 19: 530–535. 112 Oreamuno S, Lekovic V, Kenney EB, Carranza FA, Takei HH, Prokic B. Comparative clinical study of porous hydroxyapatite and decalcified freeze-dried bone in human periodontal defects. J Periodontol 1990: 61: 399–404. 113 Ouhayoun J-P. Bone grafts and biomaterials used as bone graft substitutes. In: NK Lang, T Karring, J Lindhe, editors. Proceedings of the 2nd European Workshop on Periodontology. Chicago: Quintessence Publishing, 1997: 313–360. 114 Park J, Lee J, Park Y, Rhee S, Lee S, Kim T, Seol Y, Lee Y, Ku Y, Rhyu I, Han S, Chung C. Enhanced bone regeneration in beagle dogs with bovine bone mineral coated with a synthetic oligopeptide. J Periodontol 2007: 78: 2150–2155. 115 Pecora G, Andreana S, Margarone JE, Covani U, Sottosanti J. Bone regeneration with a calcium sulfate barrier. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997: 84: 424–429. 116 Pehling S, Pippig SD, Hellerbrand K, Siedler M, Schutz A, Dony C. Superior effect of MD05 beta-tricalcium phosphate coated with recombinant human growth/differentiation factor-5, compared to conventional bone substitutes in the rat calvarial defect model. J Periodontol 2006: 77: 1582–1590. 117 Peltier LF. The use of plaster of Paris to fill large defects in bone: a preliminary report. Clin Orthop 2001: 382: 3–5. 118 Pini Prato GP, Rotundo R, Magnani C, Soranzo C. Tissue engineering technology for gingival augmentation procedures: a case report. Int J Periodontics Restorative Dent 2000: 20: 552–559. 119 Pini Prato GP, Rotundo R, Magnani C, Soranzo C, Muzzi L, Cairo F. An autologous cell hyaluronic acid graft technique for gingival augmentation: a case series. J Periodontol 2003: 74: 262–267. 120 Pischon N, Zimmermann B, Bernimoulin JP, Hagewald S. Effects of an enamel matrix derivative on human osteoblasts and PDL cells grown in organoid cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006: 102: 551–557. 121 Reddy MS. Achieving gingival esthetics. J Am Dent Assoc 2003: 134: 295–304. 122 Rezania A, Healy KE. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999: 17: 615–623. 123 Richard JL, Parer-Richard C, Daures JP, Clouet S, Vannereau D, Bringer J, Rodier M, Jacob C, Comte-Bardonnet M. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 1995: 18: 64–69. 124 Ripamonti U, Heliotis M, Van Den Heever B, Van Wyk J. Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus). J Periodontal Res 1994: 29: 439–445. 125 Rocchietta I, Dellvia C, Nevins M, Simion M. Bone regenerated via rhPDGF-BB and a deproteinized bovine bone matrix: backscattered electron microscopic element analysis. Int J Periodontics Restorative Dent 2007: 27: 539–545. 126 Rosenblum SF, Frenkel S, Ricci J
Referência(s)